3-7 Inflammatory Breast Cancer Outcome With Epirubicin-Based Induction and Maintenance Chemotherapy: Ten-Year Results From the French Adjuvant Study Group GETIS 02 Trial

M. Cristofanilli

doi:10.1016/S1043-321X(07)80301-8

3-7 Inflammatory Breast Cancer Outcome With Epirubicin-Based Induction and Maintenance Chemotherapy: Ten-Year Results From the French Adjuvant Study Group GETIS 02 Trial

M. Cristofanilli

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	246-247
Number of pages	2
Journal	Breast Diseases
Volume	18
Issue number	3
DOIs	https://doi.org/10.1016/S1043-321X(07)80301-8
State	Published - Oct 2007

ASJC Scopus subject areas

Surgery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1043-321X(07)80301-8

Cite this

@article{bde5b48f07584da5860d32eab6139bd1,

title = "3-7 Inflammatory Breast Cancer Outcome With Epirubicin-Based Induction and Maintenance Chemotherapy: Ten-Year Results From the French Adjuvant Study Group GETIS 02 Trial",

author = "M. Cristofanilli",

year = "2007",

month = oct,

doi = "10.1016/S1043-321X(07)80301-8",

language = "English (US)",

volume = "18",

pages = "246--247",

journal = "Breast Diseases",

issn = "1043-321X",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - 3-7 Inflammatory Breast Cancer Outcome With Epirubicin-Based Induction and Maintenance Chemotherapy

T2 - Ten-Year Results From the French Adjuvant Study Group GETIS 02 Trial

AU - Cristofanilli, M.

PY - 2007/10

Y1 - 2007/10

UR - http://www.scopus.com/inward/record.url?scp=34548431586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548431586&partnerID=8YFLogxK

U2 - 10.1016/S1043-321X(07)80301-8

DO - 10.1016/S1043-321X(07)80301-8

M3 - Article

AN - SCOPUS:34548431586

SN - 1043-321X

VL - 18

SP - 246

EP - 247

JO - Breast Diseases

JF - Breast Diseases

IS - 3

ER -

3-7 Inflammatory Breast Cancer Outcome With Epirubicin-Based Induction and Maintenance Chemotherapy: Ten-Year Results From the French Adjuvant Study Group GETIS 02 Trial

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this